National Pharmaceutical Corp., Spencer Pharmaceutical deal

Under a preliminary deal, Spencer and National will develop Alzheimer's disease and Parkinson's disease treatments using Spencer's drug delivery platform. The preliminary deal includes a swap of 20 mi...